At this time, generic Avodart (dutasteride) is not available in the United States. For your safety, you should not buy anything claiming to be "generic Avodart" until an approved version is available. The earliest predictable date that an approved generic could become available is in 2015, when the next patent for Avodart expires.
Avodart® (dutasteride) is a prescription medication that has been licensed to treat an enlarged prostate. Enlarged prostate is also known as benign prostatic hyperplasia, benign prostatic hyperplasia, or BPH.
Avodart is manufactured by GlaxoSmithKline. It is currently under the protection of a patent that prevents any generic Avodart from being manufactured in the United States. Yet, if you search the Internet for "generic Avodart," you may find a number of companies selling it. The fact is that these medicines could be fake, substandard, and potentially dangerous.
There may be a generic Avodart available from another country, but there is really no way of knowing if you are getting genuine Avodart or not. You should not buy any "generic Avodart" until there is an approved generic available.
When Will a Generic Version Be Available?
The first patent for Avodart expired in 2013. Yet, no generic versions are available. This suggests that another patent, set to expire in November 2015, is still protecting the drug from generic competition. This is the earliest predictable date that a generic version of Avodart could become available.
However, there are other circumstances that could come up to extend the exclusivity period of Avodart beyond 2015. These circumstances could include such things as other patents for specific Avodart uses or lawsuits. Once Avodart goes off-patent, there may be several companies that manufacture a generic Avodart drug.